The prognostic value of the derived neutrophil-to-lymphocyte ratio (dNLR) in patients treated with immune checkpoint inhibitors

被引：0
|
作者：
William J. Mullally
John Greene
Emmet J. Jordan
Anne M. Horgan
Miriam O’Connor
Paula M. Calvert
机构：
[1] University Hospital Waterford,Department of Medical Oncology
来源：
Irish Journal of Medical Science (1971 -) | 2023年 / 192卷
关键词：
Checkpoint inhibitors; Derived neutrophil-to-lymphocyte ratio; Immunotherapy biomarkers; Neutrophil-to-lymphocyte ratio;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：83 / 87
页数：4
相关论文
共 50 条
  • [1] The prognostic value of the derived neutrophil-to-lymphocyte ratio (dNLR) in patients treated with immune checkpoint inhibitors
    Mullally, William J.
    Greene, John
    Jordan, Emmet J.
    Horgan, Anne M.
    O'Connor, Miriam
    Calvert, Paula M.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (01) : 83 - 87
  • [2] The prognostic value of derived neutrophil-to-lymphocyte ratio in patients treated with checkpoint inhibitors
    Mullally, W. J.
    Greene, J. P.
    Cahill, T.
    Ryan, M. B.
    Horgan, A.
    Jordan, E. J.
    O'Connor, M.
    Calvert, P. M.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S716 - S717
  • [3] Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Outcome of Immune Checkpoint Inhibitors
    Xie, Xianhe
    Liu, Junjin
    Yang, Haitao
    Chen, Huijuan
    Zhou, Sijing
    Lin, Heng
    Liao, Ziyuan
    Ding, Yin
    Ling, Liting
    Wang, Xuewen
    [J]. CANCER INVESTIGATION, 2019, 37 (06) : 265 - 274
  • [4] Prognostic value of neutrophil-to-lymphocyte ratio in gastric cancer patients treated with immune checkpoint inhibitors: A meta-analysis
    Li, Li-Li
    Pan, Li-Sha
    [J]. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2023, 39 (08): : 842 - 852
  • [5] Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis
    Yang, Tao
    Hao, Lizheng
    Yang, Xinyu
    Luo, Changyong
    Wang, Guomi
    Cai, Caroline Lin
    Qi, Shuo
    Li, Zhong
    [J]. BMJ OPEN, 2021, 11 (09):
  • [6] Decrease in derived neutrophil-to-lymphocyte ratio (dNLR) related to immune checkpoint inhibitors (ICI) benefit in patients with metastatic urothelial carcinoma (mUC)
    Oberoi, H. K.
    Ghiglione, L.
    Gorria Puga, T.
    Fernandez Manas, L.
    Ferrer Mileo, L.
    Orrillo Sarmiento, M.
    Prat, A.
    Reig Torras, O.
    Mellado, B.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S596 - S597
  • [7] Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors
    Machet, L.
    Zaragoza, J.
    Finon, A.
    Garnier, M.
    Maillard, H.
    Caille, A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (01) : 224 - 224
  • [8] Predictability of early changes in derived neutrophil-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
    Lim, Jeong Uk
    Kang, Hye Seon
    Yeo, Chang Dong
    Kim, Ju Sang
    Park, Chan Kwon
    Kim, Jin Woo
    Kim, Seung Joon
    Lee, Sang Haak
    [J]. JOURNAL OF THORACIC DISEASE, 2021, 13 (05) : 2824 - 2832
  • [9] Prognostic value of neutrophil-to-lymphocyte ratio in patients with glioblastoma
    George A. Alexiou
    Evrysthenis Vartholomatos
    Spyridon Voulgaris
    [J]. Journal of Neuro-Oncology, 2013, 115 : 521 - 522
  • [10] Prognostic value of neutrophil-to-lymphocyte ratio in patients with glioblastoma
    Alexiou, George A.
    Vartholomatos, Evrysthenis
    Voulgaris, Spyridon
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2013, 115 (03) : 521 - 522
12345